“…The clinical framework that encompasses healthcare for patients with CP and SB has been largely confined to issues that arise during childhood and adolescence. Despite the shortage of surveillance research to evaluate lifespan health and developmental trajectories in both of these populations, there is ample indication that adults living with CP and SB have a significant and progressive functional decline, inadequate muscle and bone development, increased obesity, and risk for secondary chronic disease (Dosa et al, 2009; Lampe, Grassl, Mitternacht, Gerdesmeyer, & Gradinger, 2006; Lidal, Lundberg Larsen, & Hoff, 2019; Marreiros, Monteiro, Loff, & Calado, 2010; Moreau, Li, Geaghan, & Damiano, 2008; Peterson, Zhang, Haapala, Wang, & Hurvitz, 2015; Polfuss, Bandini, & Sawin, 2017; Trinh et al, 2017; Whitney et al, In Press; D. G. Whitney et al, 2018). However, there have been very few studies to examine psychological morbidity among adults living with CP or SB (Bellin et al, 2010; Dicianno et al, 2015; Smith et al, 2018; Whitney et al, 2019a), and no current studies have examined the longitudinal trends of a broad array of mental health disorders in these populations.…”